Effect of convalescent plasma as complementary treatment in patients with moderate COVID-19 infection.
Baldeón ME, Maldonado A, Ochoa-Andrade M, Largo C, Pesantez M, Herdoiza M, Granja G, Bonifaz M, Espejo H, Mora F, Abril-López P, Armijo LKR, Pacheco V, Salazar R, Reinthaller S, Zertuche F, Fornasini M.
Baldeón ME, et al. Among authors: espejo h.
Transfus Med. 2022 Apr;32(2):153-161. doi: 10.1111/tme.12851. Epub 2022 Jan 9.
Transfus Med. 2022.
PMID: 35001439
Clinical Trial.